biotech / news / / City A.M.
Haleon takes hit from ‘weak cold and flu season’ but Sensodyne shines.
Haleon's first-quarter sales volumes fell 0.2% due to a double-digit decline in cold and flu products.
KEY POINTS
- Sensodyne toothpaste sales grew 10%, now making India its second-largest market after the US.
- North America returned to growth for Haleon, achieving a 1% sales increase this quarter.
- Hedge fund Marshall Wace disclosed its first public short position in Haleon in May 2024.
COMPANIES
Summarized by Newsio from City A.M.. How we summarize →